JP2024105284A5 - - Google Patents

Download PDF

Info

Publication number
JP2024105284A5
JP2024105284A5 JP2024065950A JP2024065950A JP2024105284A5 JP 2024105284 A5 JP2024105284 A5 JP 2024105284A5 JP 2024065950 A JP2024065950 A JP 2024065950A JP 2024065950 A JP2024065950 A JP 2024065950A JP 2024105284 A5 JP2024105284 A5 JP 2024105284A5
Authority
JP
Japan
Prior art keywords
rnai construct
seq
nucleotides
pnpla3
duplex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024065950A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024105284A (ja
Filing date
Publication date
Priority claimed from JP2021532216A external-priority patent/JP2022511550A/ja
Application filed filed Critical
Publication of JP2024105284A publication Critical patent/JP2024105284A/ja
Publication of JP2024105284A5 publication Critical patent/JP2024105284A5/ja
Pending legal-status Critical Current

Links

JP2024065950A 2018-12-10 2024-04-16 PNPLA3発現を阻害するためのRNAiコンストラクト及びその使用方法 Pending JP2024105284A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201862777714P 2018-12-10 2018-12-10
US62/777,714 2018-12-10
JP2021532216A JP2022511550A (ja) 2018-12-10 2019-12-10 PNPLA3発現を阻害するためのRNAiコンストラクト
PCT/US2019/065481 WO2020123508A2 (en) 2018-12-10 2019-12-10 Rnai constructs for inhibiting pnpla3 expression and methods of use thereof

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2021532216A Division JP2022511550A (ja) 2018-12-10 2019-12-10 PNPLA3発現を阻害するためのRNAiコンストラクト

Publications (2)

Publication Number Publication Date
JP2024105284A JP2024105284A (ja) 2024-08-06
JP2024105284A5 true JP2024105284A5 (cg-RX-API-DMAC7.html) 2025-03-07

Family

ID=69024749

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021532216A Pending JP2022511550A (ja) 2018-12-10 2019-12-10 PNPLA3発現を阻害するためのRNAiコンストラクト
JP2024065950A Pending JP2024105284A (ja) 2018-12-10 2024-04-16 PNPLA3発現を阻害するためのRNAiコンストラクト及びその使用方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2021532216A Pending JP2022511550A (ja) 2018-12-10 2019-12-10 PNPLA3発現を阻害するためのRNAiコンストラクト

Country Status (22)

Country Link
US (2) US12674166B2 (cg-RX-API-DMAC7.html)
EP (1) EP3894555A2 (cg-RX-API-DMAC7.html)
JP (2) JP2022511550A (cg-RX-API-DMAC7.html)
KR (1) KR20210102932A (cg-RX-API-DMAC7.html)
CN (2) CN121320339A (cg-RX-API-DMAC7.html)
AR (1) AR117297A1 (cg-RX-API-DMAC7.html)
AU (1) AU2019396419B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021011061A2 (cg-RX-API-DMAC7.html)
CA (1) CA3121510A1 (cg-RX-API-DMAC7.html)
CL (1) CL2021001489A1 (cg-RX-API-DMAC7.html)
CO (1) CO2021008997A2 (cg-RX-API-DMAC7.html)
CR (1) CR20210371A (cg-RX-API-DMAC7.html)
EA (1) EA202191629A1 (cg-RX-API-DMAC7.html)
IL (1) IL283473A (cg-RX-API-DMAC7.html)
JO (1) JOP20210142A1 (cg-RX-API-DMAC7.html)
MX (2) MX2021006784A (cg-RX-API-DMAC7.html)
PE (1) PE20211225A1 (cg-RX-API-DMAC7.html)
PH (1) PH12021551326A1 (cg-RX-API-DMAC7.html)
SG (1) SG11202105711SA (cg-RX-API-DMAC7.html)
TW (1) TW202039843A (cg-RX-API-DMAC7.html)
UY (1) UY38503A (cg-RX-API-DMAC7.html)
WO (1) WO2020123508A2 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112017021053A2 (en) 2015-04-13 2018-08-14 Alnylam Pharmaceuticals, Inc. angiopoietin type 3 (angpt13) irna compositions and methods of use thereof
AR113490A1 (es) * 2017-12-12 2020-05-06 Amgen Inc CONSTRUCCIONES DE ARNi PARA INHIBIR LA EXPRESIÓN DE PNPLA3 Y MÉTODOS DE USO DE LAS MISMAS
CA3121510A1 (en) 2018-12-10 2020-06-18 Amgen Inc. Rnai constructs for inhibiting pnpla3 expression and methods of use thereof
WO2021154791A1 (en) 2020-01-28 2021-08-05 Regeneron Pharmaceuticals, Inc. Non-human animals comprising a humanized pnpla3 locus and methods of use
KR20230171431A (ko) * 2021-04-14 2023-12-20 다이서나 파마수이티컬, 인크. Pnpla3 발현을 조절하기 위한 조성물 및 방법
WO2022256395A1 (en) * 2021-06-02 2022-12-08 Alnylam Pharmaceuticals, Inc. Patatin-like phospholipase domain containing 3 (pnpla3) irna compositions and methods of use thereof
US20250243491A1 (en) * 2021-09-01 2025-07-31 Aligos Therapeutics, Inc. Pnpla3-targeting short interfering rna (sirna) molecules and uses thereof
WO2024023256A1 (en) * 2022-07-27 2024-02-01 E-Therapeutics Plc Nucleic acid compounds
JP2025542119A (ja) * 2022-12-07 2025-12-25 シャンハイ アルゴ バイオファーマシューティカル カンパニー,リミテッド パタチン様ホスホリパーゼドメイン含有3(pnpla3)の発現を阻害するための組成物及び方法
CN121294438A (zh) * 2022-12-19 2026-01-09 昂拓生物医药有限公司 高级rna靶向(arnatar)
CN121152879A (zh) * 2023-02-14 2025-12-16 基愈治疗公司 经修饰的双链rna药剂
WO2024182446A2 (en) * 2023-02-28 2024-09-06 Aligos Therapeutics, Inc. Pnpla3-targeting short interfering rna (sirna) molecules and uses thereof
WO2024249328A2 (en) * 2023-05-26 2024-12-05 Adarx Pharmaceuticals, Inc. Sod1-modulating compositions and methods of use thereof

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5744101A (en) 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
US5714331A (en) 1991-05-24 1998-02-03 Buchardt, Deceased; Ole Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility
US5719262A (en) 1993-11-22 1998-02-17 Buchardt, Deceased; Ole Peptide nucleic acids having amino acid side chains
US5539082A (en) 1993-04-26 1996-07-23 Nielsen; Peter E. Peptide nucleic acids
DE69233087T2 (de) 1991-11-22 2003-12-24 Affymetrix, Inc. (N.D.Ges.D.Staates Delaware) Verfahren zur Herstellung von Polymerarrays
US5981505A (en) 1993-01-26 1999-11-09 The Trustees Of The University Of Pennsylvania Compositions and methods for delivery of genetic material
US5837533A (en) 1994-09-28 1998-11-17 American Home Products Corporation Complexes comprising a nucleic acid bound to a cationic polyamine having an endosome disruption agent
US5556752A (en) 1994-10-24 1996-09-17 Affymetrix, Inc. Surface-bound, unimolecular, double-stranded DNA
US5840710A (en) 1994-12-09 1998-11-24 Genzyme Corporation Cationic amphiphiles containing ester or ether-linked lipophilic groups for intracellular delivery of therapeutic molecules
US5981501A (en) 1995-06-07 1999-11-09 Inex Pharmaceuticals Corp. Methods for encapsulating plasmids in lipid bilayers
JP4335310B2 (ja) 1995-06-07 2009-09-30 ザ ユニバーシティ オブ ブリティッシュ コロンビア 疎水性脂質−核酸複合中間体を通して調製される脂質−核酸粒子、及び遺伝子移送のための使用
US7422902B1 (en) 1995-06-07 2008-09-09 The University Of British Columbia Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
US5545531A (en) 1995-06-07 1996-08-13 Affymax Technologies N.V. Methods for making a device for concurrently processing multiple biological chip assays
US5854033A (en) 1995-11-21 1998-12-29 Yale University Rolling circle replication reporter systems
US6217900B1 (en) 1997-04-30 2001-04-17 American Home Products Corporation Vesicular complexes and methods of making and using the same
WO1999001579A1 (en) 1997-07-01 1999-01-14 Isis Pharmaceuticals, Inc. Compositions and methods for the delivery of oligonucleotides via the alimentary canal
ATE237312T1 (de) 1998-07-20 2003-05-15 Protiva Biotherapeutics Inc In liposomen verkapselte nukleinsäurekomplexe
US7491805B2 (en) 2001-05-18 2009-02-17 Sirna Therapeutics, Inc. Conjugates and compositions for cellular delivery
US7833992B2 (en) 2001-05-18 2010-11-16 Merck Sharpe & Dohme Conjugates and compositions for cellular delivery
US6693187B1 (en) 2000-10-17 2004-02-17 Lievre Cornu Llc Phosphinoamidite carboxlates and analogs thereof in the synthesis of oligonucleotides having reduced internucleotide charge
US7109165B2 (en) 2001-05-18 2006-09-19 Sirna Therapeutics, Inc. Conjugates and compositions for cellular delivery
US20030130186A1 (en) 2001-07-20 2003-07-10 Chandra Vargeese Conjugates and compositions for cellular delivery
US9181551B2 (en) 2002-02-20 2015-11-10 Sirna Therapeutics, Inc. RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
CA2487274A1 (en) 2002-05-06 2003-11-13 Nucleonics Inc. Spermine chemically linked to lipids and cell-specific targeting molecules as a transfection agent
US8017762B2 (en) 2003-04-17 2011-09-13 Alnylam Pharmaceuticals, Inc. Modified iRNA agents
US7851615B2 (en) 2003-04-17 2010-12-14 Alnylam Pharmaceuticals, Inc. Lipophilic conjugated iRNA agents
EP2669377A3 (en) 2003-04-17 2015-10-14 Alnylam Pharmaceuticals Inc. Modified iRNA agents
US7723509B2 (en) 2003-04-17 2010-05-25 Alnylam Pharmaceuticals IRNA agents with biocleavable tethers
WO2008131419A2 (en) 2007-04-23 2008-10-30 Alnylam Pharmaceuticals, Inc. Glycoconjugates of rna interference agents
EP2229186A2 (en) 2007-12-04 2010-09-22 Alnylam Pharmaceuticals Inc. Carbohydrate conjugates as delivery agents for oligonucleotides
WO2010028110A2 (en) 2008-09-04 2010-03-11 Board Of Regents, The University Of Texas System Sequence variations in pnpla3 associated with hepatic steatosis
CA2839896A1 (en) 2011-06-21 2012-12-27 Alnylam Pharmaceuticals, Inc. Assays and methods for determining activity of a therapeutic agent in a subject
AR090905A1 (es) 2012-05-02 2014-12-17 Merck Sharp & Dohme Conjugados que contienen tetragalnac y peptidos y procedimientos para la administracion de oligonucleotidos, composicion farmaceutica
WO2014205451A2 (en) 2013-06-21 2014-12-24 Isis Pharmaceuticals, Inc. Compositions and methods for modulation of target nucleic acids
JP2018510621A (ja) * 2015-02-13 2018-04-19 アルナイラム ファーマシューティカルズ, インコーポレイテッドAlnylam Pharmaceuticals, Inc. パタチン様ホスホリパーゼドメイン含有3(PNPLA3)iRNA組成物およびその使用方法
WO2017048620A1 (en) * 2015-09-14 2017-03-23 Alnylam Pharmaceuticals, Inc. Polynucleotide agents targeting patatin-like phospholipase domain containing 3 (pnpla3) and methods of use thereof
US10036024B2 (en) * 2016-06-03 2018-07-31 Purdue Research Foundation siRNA compositions that specifically downregulate expression of a variant of the PNPLA3 gene and methods of use thereof for treating a chronic liver disease or alcoholic liver disease (ALD)
JP7160833B2 (ja) 2017-04-13 2022-10-25 サイロパ ビー.ブイ. 抗sirpアルファ抗体
CA3065523A1 (en) 2017-06-02 2018-12-06 Wave Life Sciences Ltd. Oligonucleotide compositions and methods of use thereof
US11603532B2 (en) * 2017-06-02 2023-03-14 Wave Life Sciences Ltd. Oligonucleotide compositions and methods of use thereof
AR113490A1 (es) 2017-12-12 2020-05-06 Amgen Inc CONSTRUCCIONES DE ARNi PARA INHIBIR LA EXPRESIÓN DE PNPLA3 Y MÉTODOS DE USO DE LAS MISMAS
CA3121510A1 (en) 2018-12-10 2020-06-18 Amgen Inc. Rnai constructs for inhibiting pnpla3 expression and methods of use thereof
SG11202105900UA (en) 2018-12-10 2021-07-29 Amgen Inc CHEMICALLY-MODIFIED RNAi CONSTRUCTS AND USES THEREOF

Similar Documents

Publication Publication Date Title
JP2022078069A (ja) 二本鎖RNAによるα-1アンチトリプシンの特異的阻害のための方法及び組成物
JP2022511550A5 (cg-RX-API-DMAC7.html)
JP2021506238A5 (cg-RX-API-DMAC7.html)
JP2011505833A5 (cg-RX-API-DMAC7.html)
JP2011511636A5 (cg-RX-API-DMAC7.html)
JP2014527401A5 (cg-RX-API-DMAC7.html)
JP2009513144A5 (cg-RX-API-DMAC7.html)
WO2007056153B1 (en) Peptide-dicer substrate rna conjugates as delivery vehicles for sirna
CA3189861A1 (en) Dux4 inhibitors and methods of use thereof
EP4282966A1 (en) Oligonucleotides conjugated to oleic acid and uses thereof
JP2023503635A (ja) Rna分子を合成する方法
JP2017528441A5 (cg-RX-API-DMAC7.html)
JP2022534402A5 (cg-RX-API-DMAC7.html)
JP2009531433A5 (cg-RX-API-DMAC7.html)
JP2024512635A5 (cg-RX-API-DMAC7.html)
JP2014050389A (ja) マイクロ−rnaおよびその前駆体にハイブリダイズしうる核酸を用いるエリスロポエチンの増加
US20250376684A1 (en) Threose nucleic acid antisense oligonucleotides and methods thereof
TW202309286A (zh) 作為新穎基因靜默技術的非對稱短雙股dna及其應用
JP2025512771A5 (cg-RX-API-DMAC7.html)
JP2021513851A5 (cg-RX-API-DMAC7.html)
US20240336920A1 (en) Threose nucleic acid antisense oligonucleotides and methods thereof
CN102533742B (zh) 一种双链核苷酸序列、含其的重组质粒及其构建方法
CN121311592A (zh) 用于调节jak1表达的双链寡核苷酸
CA3254112A1 (en) ARNI CONSTRUCTIONS THAT INHIBIT PNPLA3 EXPRESSION AND THEIR METHODS OF USE
CN115807048A (zh) 一种制备双链rna的方法